Biomarker: F312-IgE Swordfish
Overview
Swordfish (Xiphias gladius) is a marine bony fish consumed as fillet and in processed fish products. It is an exposure-associated food allergen within the fish category and can cause IgE-mediated symptoms ranging from oral, skin, gastrointestinal, and respiratory symptoms to anaphylaxis. Exposure usually occurs through ingestion, although contact with fish or inhalation of aerosolized proteins during processing can also cause reactions. Serum swordfish-specific IgE testing may help evaluate suspected sensitization, but results must be interpreted with the clinical history because sensitization does not by itself establish clinical allergy.
Clinical Use Cases
Evaluation of suspected IgE-mediated fish allergy: Supports assessment when symptoms occur shortly after eating swordfish or another fish.
Serum-specific IgE assessment: Measures IgE antibodies directed against swordfish extract in a blood sample. In one adult fish-allergic population, swordfish-specific IgE detected only 50% of reported swordfish-allergic cases at the study threshold, illustrating that a negative result does not always exclude clinical reactivity.
Correlation with exposure symptoms: Helps assess whether reported urticaria, angioedema, oral symptoms, gastrointestinal symptoms, wheezing, or anaphylaxis may be associated with swordfish exposure.
Assessment with clinical history and other testing: Results may be considered alongside the timing and reproducibility of reactions, skin testing when appropriate, testing to other fish species, and component testing.
Differentiation of fish sensitization patterns: May help distinguish broad fish sensitization from selective sensitization to swordfish or a limited group of fish species.
Confirmation of uncertain cases: A medically supervised oral food challenge may be considered when the history and laboratory results do not adequately establish whether swordfish is clinically tolerated or reactive. This procedure, rather than specific IgE alone, can confirm or exclude allergy to a particular fish species.
Measurement Methods
Allergen-specific IgE testing: In-vitro immunoassay of serum or blood for IgE antibodies directed against swordfish extract. Results indicate sensitization and require clinical interpretation.
Component-resolved diagnostics: Measures IgE to individual fish allergenic proteins, particularly parvalbumin and, where available, other fish components such as enolase or aldolase. Swordfish contains reported allergenic proteins including a low-molecular-weight parvalbumin, enolase, aldolase, and other species-associated proteins, but routine component testing does not comprehensively represent all swordfish allergens.
Immunoassay and immunoblotting: Used primarily in clinical research to characterize IgE binding to swordfish proteins. A human case report identified IgE binding to a swordfish-specific approximately 25-kDa protein in a patient with monospecific swordfish allergy.
Skin prick testing: May provide supplementary evidence of sensitization, although commercial fish extracts may not contain all clinically relevant swordfish allergens and extract composition can vary.
Oral food challenge: A supervised exposure procedure used when necessary to determine clinical reactivity. It is not a blood test and should be performed only under appropriate medical supervision.
Test Preparation and Influencing Factors
Fasting: Fasting is generally not required for serum-specific IgE testing.
Medications: Unlike skin prick testing, most antihistamines do not interfere with the analytical measurement of serum-specific IgE. Medication review remains important for any planned skin testing or oral food challenge.
Timing of collection: Serum-specific IgE can be measured after a suspected reaction, but the timing and clinical context should be documented. A negative result does not fully exclude swordfish allergy.
Assay threshold: A reported positive threshold, such as 0.35 kUA/L in some studies, indicates detectable sensitization for that assay and is not an absolute clinical-allergy threshold.
Total IgE concentration: Very high or very low total IgE concentrations may affect the interpretation of specific IgE concentrations, particularly when results are low-level.
Age and clinical context: Interpretation should consider age, prior reactions, amount and preparation of swordfish consumed, coexisting atopic disease, and whether swordfish was definitely identified in the meal.
Food preparation: Cooking, smoking, curing, or other processing can alter the abundance or IgE recognition of individual fish allergens. A test based on one extract may not represent every exposure form.
Cross-reactive sensitization: IgE to parvalbumin or other shared fish proteins may produce positive results to several fish species without equivalent clinical reactions to each species.
Sensitization versus clinical allergy: A positive swordfish-specific IgE result demonstrates immunologic sensitization, not necessarily symptomatic allergy. Conversely, clinical reactions can occur despite undetectable swordfish-specific IgE when relevant species-specific or incompletely represented allergens are absent from the assay.
Cross-Reactivity
β-Parvalbumin: Parvalbumin is a major fish allergen and can produce IgE cross-reactivity among multiple bony fish species. Swordfish has relatively low reported parvalbumin content compared with some other fish, which may contribute to different sensitization and tolerance patterns.
Other bony fish: Serologic cross-reactivity between fish species is common, but it does not consistently predict clinical cross-allergy. In an adult fish-allergic population, swordfish-specific IgE showed poor specificity for distinguishing patients who reported swordfish allergy from those who tolerated swordfish.
Species-specific swordfish allergens: Human case reports document selective swordfish allergy in patients who tolerated other fish. Reported IgE-binding targets include an approximately 25-kDa swordfish-specific protein and other swordfish proteins, although the complete clinical importance of these components remains incompletely defined.
Enolase and aldolase: These fish allergen families occur across several fish species and may contribute to cross-sensitization, particularly in patients without detectable parvalbumin-specific IgE. Their specific contribution to swordfish allergy is less well established than that of parvalbumin.
Tropomyosin and shellfish: Tropomyosin has been reported as an allergen in some fish, including swordfish, and may contribute to possible immunologic overlap with crustacean tropomyosin. However, clinically meaningful fish-shellfish cross-allergy should not be assumed from a positive test alone.
Clinical relevance: Cross-reactive IgE findings should be interpreted separately from demonstrated clinical reactions. A supervised oral food challenge may be needed to determine whether a patient reacts to swordfish or can tolerate it.
Synonyms
Common name: Swordfish
Scientific name:Xiphias gladius
Allergen designation: F312-IgE Swordfish
Taxonomic category: Marine bony fish
This information is provided for general educational purposes and is not medical advice. Biomarker information may describe testing methods, measurements, or interpretations that vary by laboratory or specific test. For details about a particular lab test, including biomarkers measured, specimen type, collection requirements, preparation, and turnaround time, please refer to the individual test description. Talk with a licensed health care provider about your results.
